sponsored
PatientsVille.com Logo

PatientsVille

Fostex Medical Research Studies

Up-to-date List of Fostex Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Fostex Medical Research Studies

Rank Status Study
1 Recruiting A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions
Condition: Acne Vulgaris
Interventions: Drug: 3% Benzoyl Peroxide;   Drug: Neutrogena Rapid Clear;   Drug: 3% Benzoyl Peroxide Placebo
Outcome Measures: To assess the change in acne lesion swelling (height) for the 3% benzoyl peroxide gel test article relative to the vehicle gel after 4 once-daily applications.;   To assess the change in acne lesion swelling (height) for the 3% benzoyl peroxide gel test article relative to the vehicle gel at other evaluations
2 Unknown  A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne
Condition: Acne Vulgaris
Interventions: Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel alone;   Drug: clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths
Outcome Measures: Change in PGA scores of patients using combination clindamycin phosphate 1.2%/tretinoin 0.025% gel with or without benzoyl peroxide 6% foaming cloths for facial acne;   Change in Postinflammatory hyperpigmentation score at each study visit and from baseline to final visit.;   Total number of adverse events.;   Change in Subject Self Assessment Scoring Scale;   Change in Acne-Specific Quality of Life Questionnaire (Acne-QoL)
3 Recruiting To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
Condition: Acne Vulgaris
Interventions: Drug: Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel;   Drug: DUAC® Gel;   Drug: Placebo
Outcome Measures: Mean percent change from baseline to week 11 (study Day 77) for inflammatory (papules and pustules) lesions.;   Mean percent change from baseline to week 11 in the non-inflammatory lesion count;   Proportion of subjects with a clinical response of "success" at week 11
4 Unknown  Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)
Condition: Treatment of Acne Vulgaris Grade II in a Short Period of Time.
Intervention: Drug: Benzoyl peroxide and sulfur
Outcome Measure: Clinical study to evaluate the efficacy of topical medications containing benzoyl peroxide and sulfur in the regression in the short time (24 hours) of moderate acne vulgaris grade II (pimples).
5 Recruiting An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa.
Condition: Hidradenitis Suppurativa
Interventions: Drug: 10% Benzoyl Peroxide Topical Body Wash;   Drug: Provodine Topical Cream
Outcome Measures: Hidradenitis Suppurativa European Research Group (HISERG) scale;   Skin Irritation Index;   Patient reported Quality of Life Scores on the Dermatology Quality of Life Index and the Skindex-20
6 Recruiting Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris
Condition: Acne Vulgaris
Interventions: Drug: Clindamycin + BPO;   Drug: Azelaic acid
Outcome Measures: Change from Baseline of inflammatory lesion counts at Week 4;   Change from Baseline of lesion counts;   Change from Baseline of lesions by Investigator's Static Global Assessment (ISGA);   Time to 50% reduction in total lesion count;   Change from Baseline of local tolerability as assessed by investigator;   Subject's global change assessment (SGCA) of skin;   Change from Baseline of local tolerability as assessed by subject;   Subject satisfaction score at Week 12;   Measured adherence to study medication at Week 12;   Quality of Life Assessments;   Number of treatment related adverse events (AEs) and serious adverse events (SAEs)
7 Unknown  Safety and Efficacy of Skin Cleanser Contained Roselle Extract in Acne
Condition: Acne
Interventions: Other: skin cleanser contained Hibiscus sabdariffa extract;   Other: marketed skin cleanser
Outcome Measures: 1. Safety evaluation: Patch test 2. Efficacy evaluation: Acne lesions counts/ acne severity grading;   1. Safety evaluation: "a." Skin properties by visual and tactile features., "b." Biophysical parameters of skin. 2.Efficacy evaluation: Patient assessments.
8 Unknown  Acne Treatment With Active Oplon's Patches - 15-18 Years Old
Condition: Acne Vulgaris
Interventions: Device: Oplon Active Patch;   Device: Placebo Patch
Outcome Measure: Severity Score of lesion
9 Not yet recruiting Pulmonary Rehab in COPD: Response to Tyvaso
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Inhaled Treprostinil
Outcome Measures: distance walked on 6MWT;   Quality of Life
10 Recruiting Comparison of Insulin Therapy in Treating Post-Transplant Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Insulin, Isophane;   Drug: insulin glargine
Outcome Measures: change in Hemoglobin A1C (glycosylated hemoglobin);   change in hemoglobin A1C (glycosylated hemoglobin);   Mean blood glucose values;   weight change;   incidence of hypoglycemic episodes per subject
11 Recruiting Evaluate Reactogenicity and Immunogenicity of Standard-dose (SD) Versus High-dose (HD) Inactivated Influenza Vaccine Trivalent (IIV3) in Recipients of Solid Organ Transplants.
Conditions: Influenza, Human;   Transplantation Infection
Interventions: Biological: influenza trivalent inactive vaccine;   Biological: influenza trivalent inactive vaccine high dose
Outcome Measures: Number of patients with local or systemic reactions;   Measurement of strain-specific hemagglutination inhibition (HI) antibody titers;   All cause hospitalization;   All cause ED visits/unscheduled clinic visits;   Evaluate seroconversion and seroprotection rates
12 Unknown  Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections
Condition: Methicillin-resistant Staphylococcus Aureus Infection
Intervention: Other: Preoperative MRSA screening
Outcome Measures: The primary objective of this study is to compare the prevalence of MRSA colonization and its relationship to post-operative infection in patients who are currently pre-operatively MRSA screened per SOP to those who are not.;   The secondary objective is to compare medical charges associated with diagnosis and treatment of post-operative infections for these groups using cost-effectiveness analysis.
13 Not yet recruiting Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention: Drug: arginine in powder form
Outcome Measures: Change in GBM patients immune function through arginine supplementation;   Change in control group immune function through arginine supplementation
14 Recruiting Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Conditions: Carcinoma, Intraductal, Noninfiltrating;   DCIS;   Ductal Carcinoma In Situ
Interventions: Drug: Chloroquine Standard Dose (500mg/week);   Drug: Chloroquine Low Dose (250mg/week);   Procedure: Breast Biopsy
Outcome Measures: Tumor response evaluated by RECIST criteria as measured by breast MRI.;   Evaluate the safety and dosing efficacy of chloroquine in the treatment of patients with DCIS.;   Evaluate the effect of therapy on the progenitor cell yield and invasive capacity ex vivo.;   Evaluate the effect of treatment on the proteomic and molecular cytogenetic profiles of the DCIS lesions.
15 Recruiting Aerobic Exercise in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training;   Procedure: Patient Education (Placebo)
Outcome Measures: Changes in the relationships among oxygen consumption, six-minute walk distance, and measures of health related quality of life.;   Changes in the relationships among oxygen consumption, cardiac output and muscle oxygenation.
16 Recruiting Necessity of Anti-Arrhythmic Medication After Surgical Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Other: No Amiodarone
Outcome Measures: Change in Status of Rhythm Between Baseline and Follow-Up - Recurrence of Atrial Fibrillation;   Major Adverse Event Rate
17 Not yet recruiting The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy
Condition: Acne
Intervention: Drug: Repigel
Outcome Measures: 5 point Acne Score;   Lesional Counts;   Effect on Quality of Life;   Safety
18 Unknown  Atrial Fibrillation Ablation The Hybrid Approach Versus Traditional Management
Condition: Ablation of Atrial Fibrillation
Interventions: Procedure: Pulmonary vein isolation ablation procedure for atrial fibrillation;   Procedure: Hybrid procedure for ablation of atrial fibrillation;   Procedure: The Cox Maze Procedure for Ablation of Atrial Fibrillation;   Procedure: Hybrid Procedure for Left Atrium >5 cm but < 6.1 cm
Outcome Measures: Return to sinus rhythm rate;   Post procedure morbidities
19 Unknown  Safety and Efficacy Study of Acnase Creme in the Treatment of Acne Vulgaris I and II
Condition: Acne Vulgaris
Interventions: Drug: Benzoyl Peroxide 5% and Sulphur 2%;   Drug: Vehicle of Acnase
Outcome Measures: Average clinical development of target lesions of the groups for each experimental time.;   Clinical evolution of the acne through the counting of inflammatory and non - inflammatory lesions.;   Evaluation of oily skin through the clinical evaluation with four-point scale (absent, mild, moderate, intense);   Observation of occurrence and intensity of clinical parameters erythema, scaling, itching and burning through the clinical evaluation with four-point scale (absent, mild, moderate, severe).
20 Recruiting The Six Minute Walk Test: Influence of Patient Effort on Results and Interpretation
Condition: Each Patient Serves as His/Her Own Control.
Intervention: Behavioral: alternative instruction in exercise testing (6MWT)
Outcome Measures: distance meters;   oxygen saturation;   dyspnea score;   heart rate response

These studies may lead to new treatments and are adding insight into Fostex etiology and treatment.

A major focus of Fostex research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.


Discuss Fostex